Contact Us
Company Overview
|
Pipeline / Clinical Trials
|
Science & Discovery
|
Business Development
|
Investors
Overview
|
Stock Data
|
Governance
|
SEC Filings
|
News & Events
|
Presentations
|
Fundamentals
|
Information Request
Press Release Archive
Press Release Archive
2010
>
2009
>
2008
>
2007
>
2006
>
2005
>
2004
> 2003 >
2002
>
2001
December 16, 2003
NIH Scientists Accelerate Hair Growth with Tß4
October 14, 2003
RegeneRx to Present at 5th Annual Techvest Healthcare Conference
October 8, 2003
RegeneRx Successfully Completes Phase 1 Clinical Trial with Novel Wound Healing Drug
October 1, 2003
RegeneRx President/CEO J.J. Finkelstein To be Featured Guest on BIOTECH TODAY Radio Program
September 25, 2003
NIH Scientists Discover How RegeneRx’s Tß4 Promotes Angiogenesis
August 13, 2003
RegeneRx Retains FRB | Weber Shandwick to Implement Investor Relations Initiatives
July 14, 2003
RegeneRx's Tß4 Reduces Lethality and Decreases Inflammatory Mediators in Endotoxin-Induced Sepsis
June 24, 2003
RegeneRx Biopharmaceuticals to Present at BIO 2003
June 19, 2003
RegeneRx Holds 2003 Annual Stockholder's Meeting
June 11, 2003
RegeneRx Receives $2 Million Private Equity Investment
May 27, 2003
RegeneRx Completes Short Term Debt Offering
May 6, 2003
Researchers Report Thymosin Beta 4 Levels in Human Tears Decrease with Age
April 17, 2003
First Subjects Enrolled in RegeneRx's Phase I Clinical Trial
March 31, 2003
RegeneRx Reports 2002 Year-End Results
March 27, 2003
RegeneRx Forms Medical & Scientific Advisory Board
March 17, 2003
Wall Street Reporter Interviews RegeneRx CEO
March 12, 2003
RegeneRx CEO Interviewed on CEOcast
February 13, 2003
NIH Scientists Report Tß4 Effective in Dermal Wound Repair in Diabetic and Aged Animals
home
|
Contact Us
|
Resources
|
Site Map
|
Search
